BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3948928)

  • 1. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.
    Kovacs CJ; Johnke RM; Evans MJ; Emma DA; Hooker JL
    Exp Hematol; 1986 Mar; 14(3):165-72. PubMed ID: 3948928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term consequences of chemotherapeutic agents on hematopoiesis: development of altered radiation tolerance.
    Kovacs CJ; Evans MJ; Hooker JL; Johnke RM
    NCI Monogr; 1988; (6):45-9. PubMed ID: 3352788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term marrow cultures from mice with busulfan-induced chronic latent aplasia.
    Halka KG; Caro J; Erslev AJ
    J Lab Clin Med; 1987 Jun; 109(6):698-705. PubMed ID: 3585143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The regulation of hematopoietic stem cell proliferation and differentiation (CFU-S) during antigenic exposure].
    Tsyrlova IG
    Ontogenez; 1991; 22(2):152-8. PubMed ID: 1857595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects of chemotherapy on hematopoietic progenitor cells.
    Fried W; Adler S
    Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
    Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
    Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasts between the response of the mouse haemopoietic system to 5-fluorouracil and irradiation.
    Dixon R; Rosendaal M
    Blood Cells; 1981; 7(3):575-87. PubMed ID: 7039728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated surface membrane antigens on CFUs: characterization using the fluorescent activated cell sorter.
    Hasthorpe S; Rogerson J
    Exp Hematol; 1982 Jan; 10(1):9-19. PubMed ID: 7060662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F; Bernard A; Bueren JA
    Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil.
    Neta R; Keller JR; Ali N; Blanchette F; Dubois CM
    Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
    Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
    Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
    Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
    Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS; Wade PM; Quesenberry PJ
    J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemopoietic stem cells: possibility of toxic effects of 5-fluorouracil on spleen colony formation.
    Rosendaal M; Dixon R; Panayi M
    Blood Cells; 1981; 7(3):561-74. PubMed ID: 7337836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.